Safety Shot Inc (SHOT)
USD 0.45
(7.25%)
USD 0.45
(7.25%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.28 Million USD | -320.51% |
| 2022 | 800.29 Thousand USD | 107.35% |
| 2021 | -10.89 Million USD | -271.65% |
| 2020 | -2.93 Million USD | -1525.39% |
| 2019 | -180.32 Thousand USD | -11.78% |
| 2018 | -161.31 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 46.07 Thousand USD | 102.61% |
| 2024 Q2 | -514.1 Thousand USD | -1215.83% |
| 2023 Q3 | -1.77 Million USD | -1459.86% |
| 2023 Q1 | -1.04 Million USD | -230.06% |
| 2023 Q2 | -113.7 Thousand USD | 89.08% |
| 2023 FY | -1.76 Million USD | -320.51% |
| 2023 Q4 | -1.76 Million USD | 0.51% |
| 2022 Q1 | -5.31 Million USD | 51.23% |
| 2022 FY | 800.29 Thousand USD | 107.35% |
| 2022 Q4 | 800.29 Thousand USD | 188.42% |
| 2022 Q3 | -905.12 Thousand USD | 67.67% |
| 2022 Q2 | -2.79 Million USD | 47.3% |
| 2021 Q2 | -1.85 Million USD | 36.11% |
| 2021 Q3 | -25.92 Million USD | -1300.07% |
| 2021 Q4 | -10.89 Million USD | 57.99% |
| 2021 FY | -10.89 Million USD | -271.65% |
| 2021 Q1 | -2.89 Million USD | 1.1% |
| 2020 Q4 | -2.93 Million USD | -224.75% |
| 2020 Q2 | 1.91 Million USD | 26.4% |
| 2020 Q1 | 1.51 Million USD | 942.11% |
| 2020 FY | -2.93 Million USD | -1525.39% |
| 2020 Q3 | 2.34 Million USD | 22.4% |
| 2019 FY | -180.32 Thousand USD | -11.78% |
| 2019 Q4 | -180.32 Thousand USD | 0.0% |
| 2019 Q2 | -25.72 Thousand USD | 75.06% |
| 2019 Q1 | -103.13 Thousand USD | 0.0% |
| 2018 FY | -161.31 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Bright Green Corporation | 1.84 Million USD | 224.035% |
| Alpha Teknova, Inc. | 1.97 Million USD | 215.723% |
| ANI Pharmaceuticals, Inc. | 94.2 Million USD | 102.425% |
| Aquestive Therapeutics, Inc. | 74.95 Million USD | 103.048% |
| Collegium Pharmaceutical, Inc. | 435.33 Million USD | 100.525% |
| Cosmos Health Inc. | 8.59 Million USD | 126.591% |
| Journey Medical Corporation | -9.7 Million USD | 76.472% |
| Embecta Corp. | 1.31 Billion USD | 100.174% |
| Esperion Therapeutics, Inc. | 458.69 Million USD | 100.498% |
| Dynavax Technologies Corporation | 106.63 Million USD | 102.142% |
| Intra-Cellular Therapies, Inc. | -130.82 Million USD | 98.254% |
| Pacira BioSciences, Inc. | 432.74 Million USD | 100.528% |
| PainReform Ltd. | -7.95 Million USD | 71.266% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 85.389% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 85.389% |
| SCYNEXIS, Inc. | -19.35 Million USD | 88.194% |
| China SXT Pharmaceuticals, Inc. | -9.42 Million USD | 75.775% |
| Procaps Group, S.A. | 242.93 Million USD | 100.94% |
| Theratechnologies Inc. | 24.87 Million USD | 109.185% |
| Harrow Health, Inc. | 116.41 Million USD | 101.962% |
| Sonoma Pharmaceuticals, Inc. | -2.52 Million USD | 9.35% |
| Biofrontera Inc. | 4.05 Million USD | 156.321% |
| DURECT Corporation | -7.65 Million USD | 70.154% |
| Supernus Pharmaceuticals, Inc. | -33.52 Million USD | 93.186% |
| Cronos Group Inc. | -663.32 Million USD | 99.656% |
| OptiNose, Inc. | 58.06 Million USD | 103.934% |
| Ironwood Pharmaceuticals, Inc. | 623.38 Million USD | 100.366% |
| Kala Pharmaceuticals, Inc. | -14.57 Million USD | 84.324% |
| RedHill Biopharma Ltd. | -5.18 Million USD | 55.951% |
| Organogenesis Holdings Inc. | 15.01 Million USD | 115.216% |
| Guardion Health Sciences, Inc. | -6.35 Million USD | 64.08% |
| Cumberland Pharmaceuticals Inc. | 106.85 Thousand USD | 2237.747% |
| Radius Health, Inc. | 359.28 Million USD | 100.636% |
| Universe Pharmaceuticals INC | 197.2 Thousand USD | 1258.352% |
| ProPhase Labs, Inc. | 19.23 Million USD | 111.879% |
| Phibro Animal Health Corporation | 454.84 Million USD | 100.502% |
| Procaps Group S.A. | 242.93 Million USD | 100.94% |
| Alvotech | 1.06 Billion USD | 100.215% |
| TherapeuticsMD, Inc. | 3.67 Million USD | 162.109% |
| Viatris Inc. | 17.13 Billion USD | 100.013% |
| Rockwell Medical, Inc. | 4.45 Million USD | 151.265% |
| Aytu BioPharma, Inc. | -4.87 Million USD | 53.16% |
| SIGA Technologies, Inc. | -148.68 Million USD | 98.464% |
| Tilray Brands, Inc. | 158.97 Million USD | 101.437% |
| Lifecore Biomedical, Inc. | 121.89 Million USD | 101.874% |
| Shineco, Inc. | 29.29 Million USD | 107.799% |
| PetIQ, Inc. | 351.93 Million USD | 100.649% |
| Regencell Bioscience Holdings Limited | -2.9 Million USD | 21.267% |
| Incannex Healthcare Limited | -5.48 Million USD | 58.352% |
| Neurocrine Biosciences, Inc. | 177.3 Million USD | 101.288% |
| Alimera Sciences, Inc. | 55.3 Million USD | 104.13% |
| Silver Spike Investment Corp. | -32.61 Million USD | 92.995% |
| Assertio Holdings, Inc. | -32.52 Million USD | 92.977% |
| Shuttle Pharmaceuticals Holdings, Inc. | -1.48 Million USD | -53.445% |
| Petros Pharmaceuticals, Inc. | -5.06 Million USD | 54.858% |
| Clever Leaves Holdings Inc. | -4.81 Million USD | 52.547% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 72.187% |
| Avadel Pharmaceuticals plc | 4.21 Million USD | 154.171% |
| Hempacco Co., Inc. | 13.61 Million USD | 116.779% |
| Talphera, Inc. | -5.72 Million USD | 60.07% |
| Alvotech | 1.06 Billion USD | 100.215% |
| Eagle Pharmaceuticals, Inc. | 7.14 Million USD | 131.972% |
| Lantheus Holdings, Inc. | -96.71 Million USD | 97.638% |
| Currenc Group, Inc. | -16.57 Million USD | 86.216% |
| Kamada Ltd. | -46.43 Million USD | 95.08% |
| Indivior PLC | -33.95 Million USD | 93.272% |
| Evoke Pharma, Inc. | 260.57 Thousand USD | 976.67% |
| Flora Growth Corp. | -713 Thousand USD | -220.389% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 72.187% |
| Evolus, Inc. | 63.7 Million USD | 103.586% |
| HUTCHMED (China) Limited | -197.45 Million USD | 98.843% |
| Amphastar Pharmaceuticals, Inc. | 479.11 Million USD | 100.477% |
| Akanda Corp. | 3.9 Million USD | 158.5% |